Skip to main content

Table 1 Baseline characteristics of the study population across coronary artery calcification (CAC) tertiles

From: The association between coronary artery calcification and vectorcardiography in mechanically ventilated COVID-19 patients: the Maastricht Intensive Care COVID cohort

 

Tertile 1

(N = 93)

Tertile 2

(N = 54)

Tertile 3

(N = 58)

p-value

Age (years)

60.0 [51.0; 66.0]

67.0 [61.3; 71.8]

69.5 [65.0; 74.8]

 < 0.001

BMI (kg/m2)

27.8 [25.2; 31.2]

27.7 [24.9; 31.1]

27.7 [24.7; 30.7]

0.939

Gender (men, N, %)*

59 (63.4)

43 (79.6)

48 (82.8)

0.015

Smoking (N, %)**

6 (6.5)

6 (11.3)

4 (6.9)

0.561

Arrhythmia (N, %)***

5 (5.4)

5 (9.4)

11 (19.3)

0.030

Heart failure (N, %)***

0 (0.0)

2 (3.8)

3 (5.3)

0.068

Coronary artery disease (N, %)***

1 (1.1)

5 (9.4)

10 (17.5)

 < 0.001

Myocardial infarction (N, %)***

0 (0.0)

3 (5.7)

20 (35.1)

 < 0.001

Valvular disease (N, %)***

1 (1.1)

0 (0.0)

0 (0.0)

1.000

Diabetes mellitus (N, %)

7 (7.5)

11 (20.4)

20 (34.5)

 < 0.001

Chronic pulmonary disease (N, %)

9 (9.7)

8 (14.8)

10 (17.2)

0.374

Chronic kidney disease (N, %)

1 (1.1)

0 (0.0)

7 (12.1)

0.001

APACHE-II (points)

15.0 [13.0; 17.0]

14.5 [13.0; 18.0]

16.0 [14.0; 19.0]

0.004

ICU-mortality (N, %)*

30 (32.3)

21 (38.9)

36 (62.1)

0.001

QRST area (µVs)

58.0 [46.1; 79.5]

60.7 [40.1; 80.1]

65.8 [47.5; 82.1]

0.429

QRS area (µVs)

25.9 [19.4; 34.5]

27.5 [19.3; 34.4]

32.2 [26.3; 41.2]

0.006

T area (µVs)

31.0 [23.5; 50.0]

31.6 [16.8; 44.8]

30.5 [18.1; 45.1]

0.529

QRS duration (ms)

99.1 [86.3; 112.7]

101.4 [91.0; 119.4]

110.3 [94.8; 130.4]

0.011

QRS amplitude (mV)

1.0 [0.8; 1.3]

1.1 [0.8; 1.3]

1.1 [0.9; 1.4]

0.296

QTc time (ms)

408.0 (68.2)

415.7 (79.0)

427.7 (82.6)

0.298

Hs-cTnT (ng/L)

11.5 [7.0; 25.3]

14.0 [10.0; 28.0]

20.0 [12.0; 51.8]

0.002

NT-proBNP (pmol/L) (IQR)

47.6 [25.9; 122.8]

67.8 [21.0; 157.0]

92.7 [30.3; 252.8]

0.033

  1. Data are presented as means (standard deviation: ± SD), median [Q1,Q3], or counts (%). Differences were tested using the Kruskal–Wallis test, one way ANOVA or Fisher’s exact test unless indicated otherwise. APACHE-II Acute Physiology And Chronic Health Evaluation score, BMI body mass index, hs-cTnT high-sensitivity troponin-T, ICU Intensive Care Unit; NT-proBNP N-terminal pro-B-type natriuretic peptide. *X2 instead of Fisher exact test;**data missing, n = 1;***data missing, n = 2